Compare BWB & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BWB | BME |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | 322 | N/A |
| Industry | Major Banks | Trusts Except Educational Religious and Charitable |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.2M | 547.5M |
| IPO Year | N/A | 2005 |
| Metric | BWB | BME |
|---|---|---|
| Price | $16.93 | $39.93 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $22.33 | N/A |
| AVG Volume (30 Days) | ★ 49.7K | 36.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.57 | N/A |
| Revenue Next Year | $12.35 | N/A |
| P/E Ratio | $12.97 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.93 | $34.18 |
| 52 Week High | $20.30 | $42.74 |
| Indicator | BWB | BME |
|---|---|---|
| Relative Strength Index (RSI) | 29.14 | 22.68 |
| Support Level | $16.07 | $35.48 |
| Resistance Level | $17.84 | $42.55 |
| Average True Range (ATR) | 0.67 | 0.59 |
| MACD | -0.18 | -0.26 |
| Stochastic Oscillator | 14.15 | 0.00 |
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.